FDC Limited has announced a significant corporate development with its Board of Directors approving the relocation of the company's registered office on December 19, 2025. The pharmaceutical company disclosed this decision under Regulation 30 of the SEBI Listing Regulations, marking a strategic shift in its corporate headquarters location.

Proposed Office Relocation Details

The Board approved shifting the registered office from its current location to a new Mumbai address. The relocation involves moving from the existing industrial area to a more centralized business location in the financial capital.

Approval Process and Timeline

The registered office shift requires member approval through a postal ballot process, along with potential approval from the Regional Director if required. FDC Limited has appointed Mr. Sanjay Dholakia as the scrutinizer to conduct the postal ballot process in a fair and transparent manner.

E-Voting Schedule

The company will conduct the postal ballot through electronic means only, with notices sent to members whose email addresses are registered with the registrar and transfer agent. The e-voting timeline has been structured to provide adequate time for member participation.

Member Communication Process

FDC Limited will send postal ballot notices through electronic means exclusively to members whose email addresses are registered with MUFG Intime India Private Limited, the company's registrar and transfer agent. Only members whose names appear in the Register of Members or List of Beneficial Owners as of the cut-off date will be eligible to participate in the voting process.

The company has engaged NSDL to provide remote e-voting facilities to ensure seamless participation by members in the decision-making process. This digital approach aligns with modern corporate governance practices and provides convenient access for shareholders to exercise their voting rights on this important corporate matter.

FDC Limited , a prominent player in the pharmaceutical sector, has released its unaudited financial results for the second quarter and half-year ended September 30, revealing a mixed performance amid challenging market conditions.

Key Financial Highlights

Quarterly Performance Analysis

FDC Limited experienced a decline in both revenue and profitability for the quarter ended September 30, compared to the same period last year. The company's standalone revenue from operations decreased by 5.61% to ₹102,508.02 lakhs, down from ₹108,600.49 lakhs in Q2 FY2025. This decline was mirrored in the consolidated figures, with revenue falling by 5.54% to ₹103,773.60 lakhs.

The impact on profitability was more pronounced, with standalone profit after tax (PAT) declining by 31.71% to ₹12,571.32 lakhs, compared to ₹18,407.85 lakhs in the corresponding quarter of the previous year. On a consolidated basis, PAT dropped by 32.60% to ₹12,584.17 lakhs.

Half-Yearly Performance

Despite the quarterly setback, FDC Limited's half-yearly results showed some resilience. Standalone revenue for H1 FY2026 increased by 6.38% to ₹209,838.66 lakhs, up from ₹197,261.76 lakhs in H1 FY2025. Standalone PAT for the half-year also saw a modest increase of 4.78% to ₹26,897.42 lakhs.

However, the consolidated half-yearly figures painted a slightly different picture. Consolidated revenue for H1 FY2026 decreased marginally by 1.75% to ₹211,438.83 lakhs, while consolidated PAT declined by 7.59% to ₹26,897.25 lakhs compared to the same period last year.

Financial Position and Other Highlights

• The company recognized a fair value loss of ₹143.36 lakhs under other expenses in Q2 FY2026. However, for the half-year period, a net fair value gain of ₹1,905.36 lakhs was recorded under Other Income.
• Basic and diluted earnings per share for Q2 FY2026 stood at ₹7.72, down from ₹11.30 in Q2 FY2025.
• FDC Limited maintains a strong balance sheet with total assets of ₹287,821.00 lakhs as of September 30, on a standalone basis.

Management Commentary

Mohan A. Chandavarkar, Managing Director of FDC Limited, stated, "While we faced some headwinds in the second quarter, our half-yearly performance demonstrates the resilience of our business model. We remain committed to our strategic initiatives and are confident in our ability to navigate the current market challenges."

Outlook

As FDC Limited navigates through a challenging market environment, the company's focus on maintaining operational efficiency and leveraging its strong market position will be crucial. The pharmaceutical sector continues to evolve, and FDC's ability to adapt to changing market dynamics will be key to its future performance.

Investors and stakeholders will be watching closely to see how FDC Limited addresses the revenue and profitability challenges in the coming quarters, and whether the company can build on the positive aspects of its half-yearly performance to drive growth in the latter half of the fiscal year.